{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:30:51Z","timestamp":1789212651581,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1006\/clim.2002.5239","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T11:07:34Z","timestamp":1034075254000},"page":"231-236","source":"Crossref","is-referenced-by-count":45,"title":["European Surveillance of Immunoglobulin Safety\u2014Results of Initial Survey of 1243 Patients with Primary Immunodeficiencies in 16 Countries"],"prefix":"10.1006","volume":"104","author":[{"given":"Isabella","family":"Quinti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pierdominici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marziali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Donnanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Chapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Bjorkander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clim.2002.5239_RF1","first-page":"163","article-title":"Hypogammaglobulinaemia in the United Kingdom, Summary report of a Medical Research Council working-party","volume":"1","author":"Squire","year":"1969","journal-title":"Lancet"},{"key":"10.1006\/clim.2002.5239_RF2","first-page":"31","article-title":"Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Quart. J. Med."},{"key":"10.1006\/clim.2002.5239_RF3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1999.00109.x","article-title":"Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies","volume":"118","author":"Rosen","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2002.5239_RF4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(87)90494-6","article-title":"High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease","volume":"1","author":"Roifman","year":"1987","journal-title":"Lancet"},{"key":"10.1006\/clim.2002.5239_RF5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1006\/clim.2002.5239_RF6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/biol.1998.0164","article-title":"Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration","volume":"26","author":"Troccoli","year":"1998","journal-title":"Biologicals"},{"key":"10.1006\/clim.2002.5239_RF7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/10826060008544957","article-title":"Human intravenous immunoglobulin preparation and virus inactivation by pasteurization and solvent detergent treatment","volume":"30","author":"Chang","year":"2000","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1006\/clim.2002.5239_RF8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ije\/28.4.787","article-title":"A likelihood-based method of identifying contaminated lots of blood product","volume":"28","author":"Reilly","year":"1999","journal-title":"Int. J. Epidemiol."},{"key":"10.1006\/clim.2002.5239_RF9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/00912700022009477","article-title":"Product equivalence study comparing the tolerability, pharmacokinetics, and pharmacodynamics of various human immunoglobulin-G formulations","volume":"40","author":"Andresen","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1006\/clim.2002.5239_RF10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/jama.272.6.424","volume":"272","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"10.1006\/clim.2002.5239_RF11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(88)90016-2","article-title":"Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency","volume":"84","author":"Bjorkander","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1006\/clim.2002.5239_RF12","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin","volume":"331","author":"Bjoro","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2002.5239_RF13","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.1996.v110.pm8613001","article-title":"Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy","volume":"110","author":"Healey","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1006\/clim.2002.5239_RF14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/clim.2001.5132","article-title":"Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency","volume":"101","author":"Razvi","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1006\/clim.2002.5239_RF15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/92.8.433","article-title":"Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia","volume":"92","author":"Bjoro","year":"1999","journal-title":"Quart. J. Med."},{"key":"10.1006\/clim.2002.5239_RF16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2249.1997.508-ce1412.x","article-title":"Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up","volume":"110","author":"Christie","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2002.5239_RF17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1542\/peds.98.2.211","article-title":"Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin","volume":"98","author":"Jonas","year":"1996","journal-title":"Pediatrics"},{"key":"10.1006\/clim.2002.5239_RF18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/clim.2001.5036","article-title":"Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C","volume":"99","author":"Chapel","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1006\/clim.2002.5239_RF19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/adc.79.1.48","article-title":"Immunoglobulin replacement treatment by rapid subcutaneous infusion","volume":"79","author":"Gaspar","year":"1998","journal-title":"Arch. Dis. Child."},{"key":"10.1006\/clim.2002.5239_RF20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/0140-6736(93)92798-X","article-title":"Rapid subcutaneous immunoglobulin infusions in children","volume":"342","author":"Thomas","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/clim.2002.5239_RF21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/hep.510270102","article-title":"Hepatitis C viral infection in the immunosuppressed patient","volume":"27","author":"Collier","year":"1998","journal-title":"Hepatology"},{"key":"10.1006\/clim.2002.5239_RF22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2249.1995.tb06629.x","article-title":"HCV infection in patients with primary defects of immunoglobulin production","volume":"102","author":"Quinti","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2002.5239_RF23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1086\/315264","article-title":"Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection","volume":"181","author":"Tovo","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1006\/clim.2002.5239_RF24","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.4049\/jimmunol.165.8.4725","article-title":"Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency","volume":"165","author":"Bonhomme","year":"2000","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2002.5239_RF25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/clim.2001.5052","article-title":"Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency","volume":"100","author":"Cunningham-Rundles","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1006\/clim.2002.5239_RF26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2249.2000.01239.x","article-title":"Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): Role of defective CD28 costimulation","volume":"120","author":"Di Renzo","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2002.5239_RF27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1073\/pnas.91.3.1099","article-title":"CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency","volume":"91","author":"Farrington","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clim.2002.5239_RF28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00915297","article-title":"Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency","volume":"4","author":"Kruger","year":"1984","journal-title":"J. Clin. Immunol."},{"key":"10.1006\/clim.2002.5239_RF29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2249.1992.tb06932.x","article-title":"T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis","volume":"89","author":"Pandolfi","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2002.5239_RF30","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.144.10.3762","article-title":"Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency","volume":"144","author":"Sneller","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2002.5239_RF31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0090-1229(88)90117-1","article-title":"In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiency","volume":"49","author":"Stohl","year":"1988","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clim.2002.5239_RF32","first-page":"2563","article-title":"Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV","volume":"91","author":"Rockstroh","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"10.1006\/clim.2002.5239_RF33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/08892220050075264","article-title":"Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: Differences between complete and partial virologic responders?","volume":"16","author":"Gavazzi","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661602952393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661602952393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T15:07:05Z","timestamp":1682348825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661602952393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S1521661602952393"],"URL":"https:\/\/doi.org\/10.1006\/clim.2002.5239","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}